# Biomedical Maintenance Triage — Run 3 Diagnosis

## 1. Purpose

This document records the diagnosis performed after Run 3 of the biomedical equipment maintenance triage task.

Run 3 was deliberately changed from Run 2 in one primary area: the team-routing boundary was clarified so that ownership is based on whether an item is a registered biomedical equipment asset or fixed facility infrastructure.

The purpose of this diagnosis is to determine whether that intervention resolved the Run 2 routing ambiguity, whether the earlier Run 2 improvements were preserved, and what policy consequences or remaining ambiguities were exposed.

## 2. Run 3 Result

Run 3 successfully processed all 14 maintenance reports and produced:

- `evidence/run-3/run-3-output.md`
- `evidence/run-3/run-3-trajectory.md`

The trajectory records that all 14 report rows were parsed; every `equipment_id` matched a register entry; every report's equipment type matched the registered type; repeated equipment IDs were considered; blank register fields were treated as unavailable; the EQ-009 criticality statement was treated as an unverified report claim; the irrelevant document was not opened or used; no private expected-results file was accessed; and source files were not modified.

## 3. Run 2 Problem Addressed: MR-010 Routing

### Run 2 behavior

MR-010 was classified as Low and Facilities. The Run 2 reasoning treated the cracked handle and chipped casing as cosmetic damage with normal suction and applied the previous Facilities rule for non-patient-connected suction equipment.

### Run 2 diagnosis

The routing language created two textually defensible interpretations:

1. Biomedical Engineering could own physical damage to a registered device.
2. Facilities could own a non-patient-connected suction machine when no internal fault was established.

The underlying problem was that the policy used equipment type and fault type in a way that did not clearly define asset ownership.

### Run 3 intervention

Section 3 was changed so the first routing question is whether the equipment is a registered biomedical equipment asset. Registered biomedical equipment assets are owned by Biomedical Engineering regardless of whether the issue is internal, external/cosmetic, performance-related, or routine maintenance. Facilities is reserved for fixed building infrastructure and facility systems that are not themselves listed as biomedical equipment assets.

### Run 3 behavior

MR-010 is now Low, Biomedical Engineering, confidence 0.84. The reasoning explicitly states that EQ-010 is listed in the biomedical equipment register and therefore remains a Biomedical Engineering responsibility despite external/cosmetic damage and the absence of current patient connection.

### Diagnosis

The Run 3 intervention successfully resolved the specific MR-010 routing ambiguity. The result changed because of the deliberate policy clarification rather than a change to the underlying report data.

## 4. Run 2 Improvements Preserved

### 4.1 MR-009 — Oxygen/life-support threshold

MR-009 remains High and Biomedical Engineering. The agent continues to distinguish a repeated low flow-indicator reading from confirmed impairment of actual oxygen delivery. The patient's target saturation remains within range, and independent output/flow and concentration measurements remain identified as missing.

The EQ-009 register criticality statement is still treated as an unverified report claim because the current register field is blank.

**Diagnosis:** The Run 2 oxygen clarification survived Run 3 without regression.

### 4.2 Repeated equipment handling

Run 3 continues to recognize EQ-002 in MR-002/MR-013 and EQ-007 in MR-007/MR-014. MR-013 remains a possible continuation/recurrence of the unresolved MR-002 problem, and MR-014 is assessed in light of the unresolved MR-007 battery concern.

**Diagnosis:** The Run 3 routing change did not disrupt prior-report reasoning.

### 4.3 Missing-information handling

Run 3 continues to identify specific missing information rather than inventing it, including missing alternative-monitoring effectiveness for MR-004, medication/interruption details for MR-005, independent oxygen measurements for MR-009, current details for MR-013, and measured charging data/resolution status for MR-014.

**Diagnosis:** The incomplete-information behavior remains stable.

## 5. New Run 3 Observation: MR-004

MR-004 changed from Medium in Run 2 to High (provisional), confidence 0.68.

The Run 3 reasoning is that the patient is documented as stable and manual spot checks are being used, but the report does not establish that manual spot checks provide an effective alternative monitoring pathway. The agent therefore applies the explicit no-assumption rule and retains High pending confirmation.

### Diagnosis

This is a remaining policy-boundary question, not automatically an error.

Run 2's clarification defined Medium for a stable patient when a working alternative monitoring method is available. It also stated that if the report does not establish whether an effective alternative exists, the agent should not assume one.

Run 3 therefore exposes a precise evidence boundary: stable patient plus a documented workaround does not necessarily establish an effective alternative monitoring pathway.

No additional policy change is recommended at this stage because changing the rule solely to force a particular classification would risk weakening the no-assumption principle.

## 6. New Run 3 Policy Consequence: Registered Laboratory Analyzers

Run 3 routes both registered laboratory analyzer cases to Biomedical Engineering as the primary owner:

- MR-003 — QC failure / suspected calibration or measurement fault
- MR-011 — scheduled quarterly calibration due

The agent states that vendor service may be a subsequent technical escalation where manufacturer-level expertise is required.

### Diagnosis

This is a consequence of the new ownership-based routing model.

The revised policy establishes registered biomedical equipment asset → Biomedical Engineering primary ownership, while Vendor Escalation remains a specialized technical escalation route.

This is internally coherent with the revised ownership model, but it changes the interpretation of the earlier Vendor Escalation rule from a possible primary route to a secondary technical escalation for registered assets.

This should be documented as a policy consequence rather than silently treated as a defect.

## 7. Run 3 Diagnosis by Problem Type

| Problem | Run 2 status | Run 3 status | Diagnosis |
|---|---|---|---|
| MR-010 portable suction/cosmetic damage | Facilities | Biomedical Engineering | Resolved by routing clarification |
| MR-009 oxygen criticality threshold | High | High | Stable; Run 2 improvement preserved |
| MR-004 stable patient / alternative monitoring | Medium | High provisional | Remaining evidence boundary; no new change recommended |
| MR-003 analyzer routing | Vendor-oriented | Biomedical Engineering primary | Consequence of ownership-based routing; vendor remains technical escalation |
| MR-011 analyzer routing | Vendor-oriented | Biomedical Engineering primary | Same ownership-model consequence |
| Repeated equipment handling | Stable | Stable | No material regression |
| Missing-information handling | Stable | Stable | No material regression |
| Register/data-quality handling | Stable | Stable | No material regression |
| Source discipline/private-file protection | Stable | Stable | No material regression |

## 8. Context, Workspace, and Instruction Diagnosis

### Context/workspace

The Run 1 workspace problems were addressed before Run 2: the maintenance-report source was converted to a genuine CSV; data-quality notes were added; and blank register fields were explicitly documented as unavailable.

Run 3 did not identify a new data-format or workspace problem. The trajectory states that the report file was valid plain CSV with 14 data rows and that no input data file-format mismatch was encountered.

### Instructions/policy

The major Run 3 intervention was instructional/policy-based:

- registered biomedical equipment assets → Biomedical Engineering;
- fixed facility infrastructure → Facilities;
- registered portable devices are not reassigned to Facilities merely because they are not currently patient-connected.

The observed MR-010 change demonstrates that this clarification affected agent behavior.

## 9. Source and Experiment Integrity

Run 3 maintained the experiment boundaries:

- all 14 reports were processed;
- the irrelevant document was not opened or used;
- no private expected-results file was accessed;
- Run 1 and Run 2 outputs were not used as classification inputs;
- source files were not modified.

The Run 3 trajectory also records that read-only parsing dependencies were installed into the selected Python environment to support XLSX/PDF reading; no source files were changed as a result.

## 10. Overall Run 3 Conclusion

Run 3 successfully resolved the specific routing ambiguity exposed by Run 2.

The key behavioral change was:

> MR-010: Facilities → Biomedical Engineering

The change followed the newly defined ownership boundary for registered biomedical equipment assets.

At the same time, Run 3 preserved the major improvements from Run 2:

- MR-009 remains High rather than Critical pending confirmation of actual oxygen-delivery impairment;
- register claims that cannot be verified remain explicitly unverified;
- repeated equipment history is considered;
- missing information is identified without invention;
- source and private-file boundaries are respected.

Run 3 also exposed two consequences worth documenting:

1. MR-004 demonstrates a remaining evidence boundary concerning whether manual spot checks constitute an effective alternative monitoring pathway.
2. Registered laboratory analyzers are now treated as Biomedical Engineering's primary asset-ownership route, with Vendor Escalation available as a subsequent technical escalation where required.

No additional iteration is recommended solely to force a particular classification. The three-run sequence has demonstrated a traceable cycle of context/workspace diagnosis, targeted policy intervention, rerun, observed behavioral change, and preservation of prior improvements.
